Conference
SAT-183 Ledipasvir/Sofosbuvir with Ribavirin for 12 Weeks is Effective and Safe in Treatment-Naïve Genotype-3 Hepatitis C-Infected Patients in Canada
Authors
Feld J; Ramji A; Shafran S; Willems B; Marotta P; Huchet E; Vachon M-L; Svarovskaia E; Huang K; Hyland R
Volume
64
Publisher
Elsevier
Publication Date
January 1, 2016
DOI
10.1016/s0168-8278(16)01523-3
Conference proceedings
Journal of Hepatology
Issue
2
ISSN
0168-8278